STOCKHOLM and WALTHAM, Mass., Nov. 19, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi TM) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the first ...
Each year, an estimated 5,000-6,000 Americans are diagnosed with amyotrophic lateral sclerosis (ALS) — also known as Lou Gehrig’s disease — a neurodegenerative disease that leads to muscle weakness, ...
WALTHAM, Mass., May 25, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Phase 2 MERIDIAN study investigating systemic pegcetacoplan for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback